XML 97 R83.htm IDEA: XBRL DOCUMENT v3.20.4
Commitments and Contingencies (Details)
1 Months Ended 12 Months Ended 35 Months Ended
Dec. 31, 2019
USD ($)
Dec. 31, 2016
USD ($)
Dec. 31, 2020
USD ($)
plaintiff
Dec. 31, 2018
USD ($)
Dec. 31, 2020
USD ($)
Apr. 30, 2020
Other Commitments [Line Items]            
Number of plaintiffs | plaintiff     21,000      
Active pharmaceutical ingredient            
Other Commitments [Line Items]            
2021     $ 1,200,000,000   $ 1,200,000,000  
2022     486,000,000   486,000,000  
2023     192,000,000   192,000,000  
2024     70,000,000   70,000,000  
2025     55,000,000   55,000,000  
Indenix            
Other Commitments [Line Items]            
Damages awarded   $ 2,540,000,000        
Past damages vacated       $ 2,540,000,000    
Juno            
Other Commitments [Line Items]            
Damages awarded $ 585,000,000          
Running royalty rate from October 2017 27.60%          
Enhancement rate on past damages           50.00%
Running royalty rate on future sales           27.60%
Estimate of possible loss representing past sales     811,000,000   811,000,000  
Estimate of possible loss representing enhancement of past damages     389,000,000   389,000,000  
Estimate of possible loss representing royalties and prejudgment interest     172,000,000   172,000,000  
ViiV | Pending Litigation            
Other Commitments [Line Items]            
Value of damages sought         11,460,000,000  
Minimum | Juno            
Other Commitments [Line Items]            
Estimate of possible loss     0   0  
Maximum | Juno            
Other Commitments [Line Items]            
Estimate of possible loss     $ 1,400,000,000   $ 1,400,000,000